[
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 51 describes panitumumab (Vectibix, RXCUI 263034), indicated for colon, colorectal, rectal, and rectosigmoid cancers, and adenocarcinoma of the colon (MONDO:0021063, MONDO:0005575, MONDO:0006519, MONDO:0002271, MONDO:0002424; UMLS: C0007102, C1527249, C0007113, C0338106, C1327709).  This indicates panitumumab's use in treating various forms of colorectal cancer.\n\nRow 53 details temazepam (Restoril, RXCUI 10355), used to treat insomnia and sleep disorders (MONDO:0013600, MONDO:0003406; UMLS: C0917801, C0851578), highlighting its role as a hypnotic medication.\n\nRow 52 shows sofosbuvir (Sovaldi, Vosevi, RXCUI 1484911), indicated for Hepatitis C, hepatic cirrhosis, and hepatitis (MONDO:0005231, MONDO:0005155, MONDO:0002251; UMLS: C0019196, C0023890, C0019158), demonstrating its use in treating liver diseases.\n\nRow 50 lists buprenorphine and buprenorphine/naloxone (Bunavail, Suboxone, Zubsolv, RXCUI 352364), indicated for drug dependence, abuse, withdrawal syndrome, and depression (MONDO:0005303, MONDO:0002491, MONDO:0004938, MONDO:0005567, MONDO:0002050; UMLS: C1510472, C0013146, C0439857, C0152128, C0011570), showcasing its use in opioid addiction treatment.\n\nRow 54 shows dexmethylphenidate (Focalin, RXCUI 352372) with no listed indications.  This suggests missing or incomplete data for this drug's approved uses."
    }
]